News
On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 and older. The medication is an injectable branded Ebglyss and will be available ...
When a new eczema drug called Dupixent finally became available to Sawyer a few years ago, his turnaround was fast and dramatic. Within a week, his itchiness and redness started calming down.
NEW YORK (CBSNewYork)-- Treatments have not always been great for adults suffering from eczema. However, as CBS2's Dr. Max Gomez reports, a new drug may revolutionize the treatment for the very ...
A new drug that scientists hope will relieve the debilitating itching of chronic eczema has shown promising results in early trials. Dupilumab, which is injected, interferes with the activity of ...
A new drug from a clinical trial is 'doing wonders.' While Kwame Baird loves how his skin looks without the bumpy eczema, he really enjoys the new confidence he has since starting the treatment.
PITTSBURGH (KDKA) -- There's a new treatment for eczema, that's offering relief to patients. Eucrisa was approved by the Food and Drug Administration in December. It works on the overactive part ...
The Food and Drug Administration approved a new drug on Tuesday to treat serious cases of eczema. The drug, called Dupixent, is a twice-a-month injection under the skin. Patients can do it at home ...
A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch relief and clear skin for many patients in a clinical trial, without the ...
The Food and Drug Administration on Tuesday approved Sanofi and Regeneron Pharmaceutical's drug Dupixent as a treatment for moderate to severe eczema. FDA approves new eczema drug with $37k price tag ...
A new generation of treatments for severe eczema is on the horizon, which doctors say could help millions more patients gain relief from chronic outbreaks of the oozing, itchy and sometimes ...
A new case study published in the journal JAMA Dermatology reveals a young patient suffering from severe eczema along with a longstanding case of alopecia totalis – a condition resulting in the ...
Dupixent has been described as the first of its kind to treating eczema or atopic dermatitis for patients who do not respond to atopical steroids. Drug developer Regeneron Pharmaceuticals won ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results